What is DEO?
Founded in 2018 and headquartered in Genk, Belgium, DEO has developed an innovative Operating Room Efficiency Platform. This platform is designed to alleviate pressure on surgical teams, reduce overall treatment costs, and increase patient throughput without compromising the quality of care. By optimizing operating room workflows, DEO aims to address critical inefficiencies within healthcare systems, positioning itself as a key player in health tech innovation.
How much funding has DEO raised?
DEO has raised a total of $4.2M across 1 funding round:
Other Financing Round
$4.2M
Other Financing Round (2021): $4.2M with participation from Capricorn Investment Partners
Key Investors in DEO
Capricorn Investment Partners
Capricorn Investment Partners is an Australian-based investment firm that operates within the venture capital and private equity landscape, likely focusing on companies with significant growth potential.
What's next for DEO?
The recent major strategic investment suggests DEO is entering a scaling phase, likely focusing on expanding its market reach and further developing its platform's capabilities. The enterprise-level funding context implies a strategic push towards broader adoption within large healthcare networks. Future developments may include enhanced AI-driven analytics for surgical performance, integration with existing hospital information systems, and potential international expansion, solidifying its position as a leader in operational efficiency for surgical environments.
See full DEO company page
